furosemide has been researched along with dantrolene in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (9.09) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (27.27) | 29.6817 |
2010's | 7 (63.64) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Casthely, PA; Lamprou, M; Yoganathan, T | 1 |
Alkhalil, A; Allen, RJ; De Jonge, HR; Derbyshire, E; Desai, SA; Egée, S; Ginsburg, H; Hill, DA; Huber, SM; Kirk, K; Lang, F; Lisk, G; Oteng, E; Pillai, AD; Rayavara, K; Rouhani, S; Saliba, KJ; Shen, C; Solomon, T; Staines, HM; Thomas, SL; Verloo, P | 1 |
Revilla, S; Sams, SH; Stahl, DL | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Darvesh, AS; Geldenhuys, WJ; Leeper, TC; Morris, DL; Sullivan, PG; Yonutas, HM | 1 |
2 review(s) available for furosemide and dantrolene
Article | Year |
---|---|
Electrophysiological studies of malaria parasite-infected erythrocytes: current status.
Topics: Animals; Anions; Cell Membrane Permeability; Dantrolene; Erythrocytes; Furosemide; Humans; Ion Channels; Malaria, Falciparum; Membrane Transport Modulators; Nitrobenzoates; Oxidation-Reduction; Patch-Clamp Techniques; Plasmodium falciparum | 2007 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
9 other study(ies) available for furosemide and dantrolene
Article | Year |
---|---|
Dantrolene-induced hyperkalemia in a patient treated with diltiazem and metoprolol.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Calcium Channel Blockers; Cardiac Output; Coronary Artery Bypass; Coronary Artery Disease; Dantrolene; Diltiazem; Diuretics; Drug Synergism; Furosemide; Glucose; Humans; Hyperkalemia; Hypoglycemic Agents; Insulin; Male; Malignant Hyperthermia; Metoprolol; Muscle Relaxants, Central; Potassium; Pulmonary Wedge Pressure | 1988 |
Delayed Development of Malignant Hyperthermia Following Cardiopulmonary Bypass.
Topics: Androstanols; Anesthesia, General; Anesthetics, Inhalation; Anesthetics, Intravenous; Cardiopulmonary Bypass; Dantrolene; Diuretics; Etomidate; Fentanyl; Fluid Therapy; Furosemide; Humans; Isoflurane; Male; Malignant Hyperthermia; Middle Aged; Muscle Relaxants, Central; Neuromuscular Nondepolarizing Agents; Postoperative Complications; Rocuronium; Sodium Bicarbonate; Time | 2018 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Identification of small molecules that bind to the mitochondrial protein mitoNEET.
Topics: Hypoglycemic Agents; Ligands; Mitochondrial Proteins; Protein Binding; Small Molecule Libraries; Thiazolidinediones | 2016 |